<DOC>
	<DOCNO>NCT01028040</DOCNO>
	<brief_summary>This single centre , open label , non-randomised study access safety , tolerability , pharmacokinetics pharmacodynamics AZD3043 follow single dose administration Japanese subject .</brief_summary>
	<brief_title>AZD Single Ascending Dose Study In Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese male female nonchildbearing potential age ≥20 ≤ 45 suitable vein cannulation repeat venepuncture . Body weight 4590 kg Body mass index ( BMI ) ≥18.0 ≤27.0 kg/m2 Clinically normal physical finding include supine blood pressure , pulse rate , ECG , laboratory assessment relation age , judge Investigator . History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness/infection medical/surgical procedure trauma , judge Principal Investigator , within 4 week first administration investigational product . Any clinically significant abnormality clinical chemistry , haematology urinalysis judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>AZD3043</keyword>
	<keyword>Japanese healthy volunteer</keyword>
</DOC>